Search

Author/Creator Lamar, Maria

1. Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study. Issue 5 (May 2018)

Authors:
Rimassa, Lorenza; Assenat, Eric; Peck-Radosavljevic, Markus; Pracht, Marc; Zagonel, Vittorina; Mathurin, Philippe; Rota Caremoli, Elena; Porta, Camillo; Daniele, Bruno; Bolondi, Luigi; Mazzaferro, Vincenzo; Harris, William; Damjanov, Nevena; Pastorelli, Davide; Reig, María; Knox, Jennifer; Negri,...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 5(2018)
Page Start:
682
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Tivantinib, a New Option for Second-line Treatment of Advanced Hepatocellular Carcinoma? The Experience of Italian Centers. Issue 2 (March 2015)

Authors:
Rimassa, Lorenza; Santoro, Armando; Daniele, Bruno; Germano, Domenico; Gasbarrini, Antonio; Salvagni, Stefania; Masi, Gianluca; Abbadessa, Giovanni; Lamar, Maria; Goldberg, Terri; Porta, Camillo
Journal:
Tumori
Issue:
Volume 101:Issue 2(2015)
Page Start:
139
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search